Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head

NCT00490360 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT00490360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00490360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2001
Completion date
May 31, 2007
Enrollment
2,007 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the pancreatic head